The FDA said it is investigating 12 deaths linked to the antiviral Tamiflu. According to authorities in Japan, the drug is linked to a number of adverse events and could be a factor in two suicides in Japan. An FDA spokesperson said the agency is not yet requiring any label changes, but may warn against a skin reaction caused by the drug. Maker Roche issued a statement saying no there is no evidence of any dangerous link.
- see this article from The New York Times